Kansarka ugxantu

Kansarka ugxantu waa kansar ka bilaabma ugxansidaha. Ugxan sidayaashu waa xubnaha taranka haweenka ee soo saara ukunta.

Kansarka ugxansiduhu waa kansarka shanaad ee ugu badan dumarka. Waxay sababtaa dhimasho ka badan nooc kasta oo kale ee kansarka xubnaha taranka dumarka.

Sababta kansarka ugxan-sidaha lama yaqaan.

Khataraha in uu ku dhaco kansarka ugxansidaha ugxansidaha waxaa ka mid ah kuwa soo socda:

• Carruurta yar ee ay haweeneyda yeelato iyo waqtiga dambe ee ay umusho, ayaa halista ugu badan ugu jirta kansarka ugxansidaha ugxan sidaha.
• Haweenka kansarka naasaha ku dhacay ama taariikh qoys ku leh kansarka naasaha ama ugxansidaha ayaa leh halista sii kordheysa ee kansarka ugxansidaha (sababo la xiriira cilladaha ku jira hiddo-wadaha sida BRCA1 ama BRCA2).
• Haweenka qaata beddelka estrogen oo keliya (oo aan qaadan progesterone) muddo 5 sano ah ama ka badan waxay yeelan karaan halista sare ee kansarka ugxansidaha ugxan sidaha. Kiniiniyada xakameynta dhalmada, in kastoo, ay yareeyaan halista kansarka ugxan sidaha.
• Daawada bacrimintu uma badinayso halista kansarka ugxansidaha.
• Haweenka da'da weyn ayaa halista ugu badan ugu jira inuu ku dhaco kansarka ugxansidaha ugxansidaha. Inta badan dhimashada kansarka ugxan-sidaha waxay ku dhacdaa haweenka jira 55 iyo wixii ka weyn.

Calaamadaha kansarka ugxan-sidaha badanaa ma cadda. Haweenka iyo dhakhaatiirtoodu waxay inta badan ku eedeeyaan astaamaha astaamo kale oo badan. Waqtiga lagu ogaanayo kansarka, burooyinka ayaa badanaa ku faafa ugxanta ugxanta.

U tag dhakhtarkaaga haddii aad leedahay calaamadaha soo socda maalin kasta in ka badan dhowr toddobaad:

• Bararka ama bararka aagga caloosha
• Dhibaato cunida ama dareemid buuxda dhaqso (dhereg hore)
• Xanuun miskaha ama caloosha oo hoose (aagga waxaa laga yaabaa inuu "culus yahay")
• Dhabar xanuun
• Qanjirrada qanjidhada oo barara

Calaamadaha kale ee dhici kara:

• Kordhinta timaha xad dhaafka ah oo aan badnayn oo madow
• Kaadi kadis ah kadin
• Ubaahan in la kaadiyo marar badan sida caadiga ah (siyaadinta kaadida ama degdega)
• Calool fadhiga

Baadhitaanka jirka ayaa badanaa caadi noqon kara. Kansarka ugxansidaha ee ugxan, dhaqtarka waxaa laga yaabaa inuu helo calool bararsan badanaa sababta oo ah isku urursiga dareeraha (ascites).

Baaritaanka miskaha ayaa laga yaabaa inuu muujiyo ugxan sidaha ama caloosha.

Baaritaanka dhiigga ee CA-125 looma tixgelin doono baaritaanka wanaagsan ee kansarka ugxan-sidaha. Laakiin, waa la samayn karaa haddii haweeney leedahay:

• Calaamadaha kansarka ugxansidaha
• Horey ayaa looga helay kansarka ugxansidaha si loo ogaado sida wanaagsan ee daaweynta u shaqeyneyso

Tijaabooyinka kale ee laga yaabo in la sameeyo waxaa ka mid ah:

• Tirinta dhiigga oo dhameystiran iyo kiimikada kiimikada
• Tijaabada uurka (serum HCG)
• CT ama MRI ee miskaha ama caloosha
• Ultrasound ee miskaha

Qalliinka, sida laparoscopy ama laparotomy sahaminta, ayaa badanaa loo sameeyaa si loo helo sababta calaamadaha. Cad ka-qaadis ayaa la samayn doonaa si looga caawiyo samaynta cudurka.

Ma jiro shaybaar ama baaritaanka sawirka waligiis oo la muujiyey inay awood u leedahay inay si guul leh u baarto ama u ogaato kansarka ugxan-sidaha ugxan-yari marxaladihiisa hore, sidaas darteed ma jiraan baaritaanno heer-baaris oo caadi ah oo lagula taliyo xilligan.

Qalliinka waxaa loo isticmaalaa in lagu daaweeyo dhammaan heerarka kansarka ugxansidaha ugxan sidaha. Marxaladaha hore, qalliinku wuxuu noqon karaa daaweynta keliya ee loo baahan yahay. Qalliinka waxaa laga yaabaa inuu ku lug yeesho ka saarista ugxan sidayaasha iyo tuubbooyinka ugxan, ilmo-galeenka, ama dhismayaasha kale ee ku jira caloosha ama miskaha.

• Muunado meelaha muuqda ee caadiga ah si loo arko haddii kansarku ku faafay (staging)
• Ka qaad aagagga fiditaanka burooyinka (baabi'inta)

Chemotherapy waxaa loo isticmaalaa qalliinka ka dib in lagu daaweeyo wixii kansar ah ee hadhay. Chemotherapy sidoo kale waa la isticmaali karaa haddii kansarku soo laabto (soo noqosho). Dawaynta kimikalka waxaa caadi ahaan la siiyaa xididka (iyada oo loo marayo IV). Waxaa sidoo kale si toos ah loogu duri karaa caloosha caloosha (intraperitoneal, ama IP).

Daaweynta shucaaca si dhif ah ayaa loo isticmaalaa in lagu daaweeyo kansarka ugxansidaha ugxan sidaha.

Qalliinka iyo daaweynta kiimikada ka dib, raac tilmaamaha ku saabsan inta jeer ee ay tahay inaad aragto dhakhtarkaaga iyo baaritaannada ay tahay inaad sameyso.

Waad yareyn kartaa diiqada jirrada adoo ku biiraya kooxda taageerta kansarka. La wadaagida dadka kale ee leh khibradaha guud iyo dhibaatooyinka ayaa kaa caawin kara inaadan kali dareemin.

Kansarka ugxansiduhu marar dhif ah ayaa lagu ogaadaa heerarkiisa hore. Badanaa way horumarsan tahay waqtiga cudurka la ogaado:

• Ku dhowaad kalabar dumarka ayaa noolaa in ka badan 5 sano baaritaanka ka dib
• Haddii cudurka la ogaado goor hore cudurka lana daaweeyo ka hor inta uusan kansarku ku faafin meel ka baxsan ugxan sidaha, heerka badbaadada 5-sano ayaa sarreysa

La xiriir bixiyaha xanaanada caafimaadkaaga haddii aad tahay haweeney 40 sano jir ah ama ka weyn oo aan dhowaan sameyn baaritaanka miskaha. Imtixaanada miskaha ee joogtada ah waxaa lagula talinayaa dhammaan haweenka jira 20 sano ama ka weyn.

Ballan wac wac bixiyahaaga haddii aad leedahay calaamadaha kansarka ugxansidaha ugxan sidaha.

Ma jiraan talooyin caadi ah oo lagu baaro haweenka astaamo la'aan (astaamo la'aan) kansarka ugxan-sidaha. Ultrasound-ka miskaha ama baaritaanka dhiigga, sida CA-125, lama helin inuu waxtar leeyahay lagumana talinayo.

Tijaabada hida-sidaha ee BRCA1 ama BRCA2, ama hiddo-wadaha kale ee la xiriira kansarka, ayaa lagula talin karaa dumarka halista sare ugu jira kansarka ugxansidaha. Kuwani waa haween leh taariikh shaqsiyadeed ama qoys oo kansarka naasaha ama ugxansidaha ah.

Ka saarida ugxansidaha iyo tuubbooyinka ugxanta iyo suura galnimada ilmo-galeenka haweenka ku jira isbeddel la xaqiijiyay ee hiddo-wadaha BRCA1 ama BRCA2 ayaa yareyn kara halista ah inuu ku dhaco kansarka ugxan-sidaha. Laakiin, kansarka ugxansidaha ayaa laga yaabaa inuu weli ku soo baxo meelaha kale ee miskaha.

Kansarka - ugxan sidaha

• Shucaaca caloosha - dheecaanka
• Daaweynta kiimikada - waxa aad weydiiso dhakhtarkaaga
• Shucaaca miskaha - dheecaan

• Jirka anatomi ee taranka dumarka
• Ascites oo leh kansarka ugxansidaha - CT scan
• Cudurka 'Peritoneal and ovarian cancer', CT scan
• Khataraha kansarka ugxan-sidaha
• Welwelka koritaanka ugxantu
• Ilma-galeenka
• Kansarka ugxantu
• Metastasis kansarka ugxan-sidaha

Coleman RL, Liu J, Matsuo K, Thaker PH, Westin SN, Sood AK. Carcinoma ee ugxansidaha iyo tuubbooyinka ugxanta. Gudaha: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6aad ed. Philadelphia, PA: Elsevier; 2020: baab 86.

Coleman RL, Ramirez PT, Gershenson DM. Cudurrada neoplastic ee ugxansidaha: baaritaanka, epithelial aan fiicnayn iyo xun iyo neoplasms unugyada jeermiska, burooyinka stromal-xarig galmada. Gudaha: Lobo RA, Gershenson DM, Lentz GM, Valea FA, eds. Cilmiga Haweenka oo dhameystiran. 7aad ed. Philadelphia, PA: Elsevier; 2017: cutubka 33.

Websaydhka Machadka Kansarka Qaranka. Isbedelada BRCA: halista kansarka iyo baaritaanka hidda-sidaha. www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet. La cusbooneysiiyay Noofambar 19, 2020. Waxaa la helay Janaayo 31, 2021.